The analytical characteristics and clinical performance of cardiac troponin assays have evolved through several generations, with the most recent generation of assays being referred to as high sensitivity.

Laboratorians are finding that different LIS are converting unit abbreviations unintentionally, which can lead to incorrect meanings and confusion. Does your lab have any tips on how to deal with this problem?

A new epitope discovery process provides a rapid and cost-effective method for identifying relevant and accessible epitopes in advance of the development of the binding molecules, leading to a much more targeted approach.